neurology clinics (35%). This is the most important finding of this meta-analysis.
2. Under introduction (Pg 6, line 28), the authors only stated the prevalence of depression in oncology and hematology patients. Then the authors mentioned about prevalence of depression in mild cognitive impairment. I advise the authors to include prevalence of depression in the following chronic medical disorders to indicate the clinical significance. The following statement and references should be inserted:
Depression is a significant comorbidity of chronic medical disorders. The prevalence of depression in chronic medical conditions are as follows: asthma (27%) (Lu Y et al 2012) , atopic dermatitis (5%) (Lim VZ et al 2016) , chronic obstructive pulmonary disease (24.6%) (Zhang MW et al 2011) , gouty arthritis (20%) (Mak et al 2011) , rheumatoid arthritis (15%) (Ho RC et al 2011) , systemic lupus erythematosus (22%) (Mak A et al 2011) and stroke (30%) (Mak KK et al 2013) .
Please include these important references: 3. Under introduction (Pg 6, line 51), the authors stated that many previous studies have focused on depression in inpatient settings but mental disorders in outpatients are largely underestimated. The authors should discuss the economic burden of outpatients suffering from depression. Please add the following statement and reference: Depression in outpatients is associated with high indirect costs due to loss of productivity and unemployment (Ho RC et al 2013) . The combination of chronic medical illnesses and depression will lead to significant economic burden. Ho RC et al (2013) The effect of severity of depressive disorder on economic burden in a university hospital in Singapore. Expert Rev Pharmacoecon Outcomes Res. 2013 Aug;13(4):549-59. PMID:23977979 4. Under statistical analysis (Pg 10, line 9), the authors stated random-effects model was used to estimate the pooled prevalence of depressive symptoms. The authors should provide more explanation about the reasons for using random-effects model. I advise the authors to add the following statement and reference: Random-effect model attempted to generalize findings beyond the included studies by assuming that the selected studies are random samples from a larger population (Cheung MW 2012 5. Under statistical analysis (Pg 10, line 39), the authors mentioned subgroup analysis and meta-regression. It is important to provide further explanation of meta-regression.
I recommend the authors to add the following statement and reference.
For models with considerable heterogeneity, a meta-regression was performed to identify the moderators which might contribute to the heterogeneity of the effect sizes (Ho RC et al 2011).
Please include this reference:
Ho RC et al (2011) Is high homocysteine level a risk factor for cognitive decline in elderly? A systematic review, meta-analysis, and meta-regression. Am J Geriatr Psychiatry. 2011 Jul;19(7):607-17. PMID:21705865 6. Under discussion (Pg 15), the authors should discuss the most important finding of this study -the highest prevalence of depression was found in outpatient otolaryngology, dermatology and neurology clinics. I advise the authors to add the following statement and references after stating the prevalence of depression (Pg 15, line 13).
This study found outpatients from otolaryngology clinics had the highest prevalence of depression (53%). Depression was found to be an important mediator for otolaryngologic conditions such as chronic tinnitus (Trevis et al 2016) . It was not surprised that dermatology ranked the second highest and 39.0% of outpatients from dermatology clinics suffered from depression. Atopic dermatitis was found to be associated with depression (Lim VZ et al) because the skin stigmata often causes embarrassment, low confidence and sadness (Chernyshov PV et al 2016) . Atopic dermatitis is one of the most common dermatological disorders and was found to be associated with negative impact on the quality of life of patients, families and caregivers (Ho RC et al 2010a , Chernyshov PV et al 2013 . There is psychoneuroimmunology connection between depression and medical illness (Ho RC et al 2010) . The production of pro-inflammatory cytokine (e.g. IL-6) was found to be higher in patients with atopic dermatitis (Gharagozlou M et al 2013) and IL-6 was found to be raised in patients with depression (Liu et al 2012) . Raised IL-6 may cause depression in patient with atopic dermatitis. This study found 35% of outpatients from neurology clinic suffered from depression. Genetic factors (Ho RC et al 2016a) and autoantibodies (Ho RC et al 2016b) play an important role in causing neuropsychiatric complications including depression. Stroke is a common neurological disorder and causes significant health burden (Zhang et al 2017) . The burden of stroke causes depression in both stroke patients and their caregivers (Loh et al 2017) . Novel rehabilitation intervention targeting at motor deficit was designed to improve functional status and quality of life of patients with stroke (Zhang et al 2015) . This intervention might offer hope and reduce prevalence of depression in patients with stroke. 
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GENERAL COMMENTS
This is a useful and timely review, addressing the prevalence of depression in outpatients.
Overall, I think it is interesting and well-written. My major concern is the limited number of databases used to conduct the search; the general recommendation from the Cochrane Collaboration is to include at least three databases in your search strategy. There is also some fairly recent systematic review evidence to suggest that a small number of databases can result in database bias. I would recommend rerunning the search strategy using an additional database, to ensure no other relevant research is missed.
I also have some fairly minor comments to improve the manuscript.
1. For future replication of your searh strategy, it would be helpful to include your exact search terms in an appendix. 2. Did you pre-select the specialties you included in your search strategy? Is there a fully inclusive list of international specialties available? If not, there's possibility of introducing bias by having forgotten some specialties, or systematically omitted culturally specific specialties which might be referred to using different phrases or terminology. 3. What is the justification (and implication) of only including studies where patients have clinically relevant depression. Might this lead to an overestimation of prevalence? 4. In the first paragraph of the results section, it's unclear what you mean by "uncorrected outcome measures". 5. At the top of page 13 in the results, I'm not sure how meaningful it is to combine prevalence estimates into one overall pooled estimate, given the heterogeneity particularly in how depression is measured. Perhaps it's more helpful to only report them separately by depression measurement. 6. Also at the top of page 13, it seems from you eligibility criteria that having a control group was one of your inclusion criteria, yet here you mention only 8 studies with a control group. Can this be clarified. 7. No mention is made of how the variation in thresholds in the different depression measurements impacted prevalence estimates. 8. In the limitations section, it would be helpful to have a wider discussion on the implications of your finding that there may be publication bias. 9. The conclusion section mentions several implications for clinical practice, but the first implication is just a reiteration of your methods. This could be rephrased.
VERSION 1 -AUTHOR RESPONSE
Reviewer #1: Comment: This has been a large amount of work and is an important topic. I would like to see a more homogenous group of papers analyzed for example there are several papers that use the same outcome measure -you could do a more robust analysis on a smaller group of papers. Response: Thanks so much for your appreciation on our manuscript. In fact, we have performed subgroup analysis based on a smaller group of papers as you suggested to explore the source of heterogeneity. Five particular subgroups were selected considering both the outpatients" characteristics and inspection of the included studies" baseline information as follows.
[Specialties/diagnostic method]: These are the two key factors that may affect the analysis of depression prevalence.
[Study Design/area]: These factors are influenced by regional and temporal distinction and may impact the representativeness and accuracy of the epidemiological statistics.
[Age] this subgroup analysis results could also enhance or challenge the former studies. (See in Discussion Section) Also it would be good to see a tightening of diagnoses what you are including as depression or "depressive symptoms" should be clear to the reader. I agree with you that the diagnosis of depression/depressive syptomes in the inclusions criteria is the key factor to affect the pooled estimation. As was claimed in the Methods Sections (Page 8-9, Line 133-142), Studies in which depression was confirmed by validated self-report instruments or diagnostic structured interviews was included. However, the diagnostic method varied between studies and no golden diagnostic stardard was recognized yet. We accordingly conducted subgroup calculation based on different diagnostic methods to provide a more robust analysis.
You have stated that there is a paucity of research identifying cognitive impairment and go into this in some detail, yet your analysis does not include cognitive impairment. This distracts from your message. Thank you for the suggestion. We have rephrased the statement in the Introduction Section, accordingly. (Page 6-7, Line 96-101)
What recommendations can you make regarding identification of depression at outpatient clinic? Thank you for this question. We would recommend that doctors should become more aware of patients" mental disorders in daily clinical practice and have more communication with patients. We have included these remcommendations in the Discusstion Section. (Page 16, Line 272-275).
Finally some of the language at numbers need checking for accuracy. Thank youfor this suggestion. We have carefully checked the whole manuscript and corrected the inaccurate expressions
Reviewer #2: Comment (1): Under abstract (Pg 3, line 21), the authors should indicate which specialties have the highest prevalence of depression (i.e. otolaryngology clinics (53%), dermatology clinics (39%) and neurology clinics (35%). This is the most important finding of this meta-analysis. Response: Thanks for your helpful suggestion. We have reworded our result section accordingly. I recommend the authors to add the following statement and reference.
Please include this reference: Ho RC et al (2011) Is high homocysteine level a risk factor for cognitive decline in elderly? A systematic review, meta-analysis, and meta-regression. Am J Geriatr Psychiatry. 2011 Jul;19(7):607-17. PMID:21705865 Response: Thanks for your recommendation. We have added this statement and cited the reference (Page 10, Line 174-176.)
Comment (6): Under discussion (Pg 15), the authors should discuss the most important finding of this study -the highest prevalence of depression was found in outpatient otolaryngology, dermatology and neurology clinics. I advise the authors to add the following statement and references after stating the prevalence of depression (Pg 15, line 13).
This study found outpatients from otolaryngology clinics had the highest prevalence of depression (53%). Depression was found to be an important mediator for otolaryngologic conditions such as chronic tinnitus (Trevis et al 2016) . It was not surprised that dermatology ranked the second highest and 39.0% of outpatients from dermatology clinics suffered from depression. Atopic dermatitis was found to be associated with depression (Lim VZ et al) because the skin stigmata often causes embarrassment, low confidence and sadness (Chernyshov PV et al 2016) . Atopic dermatitis is one of the most common dermatological disorders and was found to be associated with negative impact on the quality of life of patients, families and caregivers (Ho RC et al 2010a , Chernyshov PV et al 2013 .
There is psychoneuroimmunology connection between depression and medical illness (Ho RC et al 2010) . The production of pro-inflammatory cytokine (e.g. IL-6) was found to be higher in patients with atopic dermatitis (Gharagozlou M et al 2013) and IL-6 was found to be raised in patients with depression (Liu et al 2012) . Raised IL-6 may cause depression in patient with atopic dermatitis. This study found 35% of outpatients from neurology clinic suffered from depression. Genetic factors (Ho RC et al 2016a) and autoantibodies (Ho RC et al 2016b) play an important role in causing neuropsychiatric complications including depression. Stroke is a common neurological disorder and causes significant health burden (Zhang et al 2017) . The burden of stroke causes depression in both stroke patients and their caregivers (Loh et al 2017) . Novel rehabilitation intervention targeting at motor deficit was designed to improve functional status and quality of life of patients with stroke (Zhang et al 2015) . This intervention might offer hope and reduce prevalence of depression in patients with stroke. 
